抄録
We have investigated the role of PPAR γ and its related genes on the pathogenesis of type 2 diabetes. Heterozygous PPARγ-deficient mice were protected from the development of insulin resistance due to adipocyte hypertrophy under a high-fat diet, whose phenotypes were abrogated by PPARγ agonist treatment. Moreover, a Pro12Ala polymorphism in the human PPARγ 2 gene, which has been reported to cause a reduction in the PPARγ activity, was associated with decreased risk of type 2 diabetes in Japanese. The protective effect of this polymorphism against type 2 diabetes has been confirmed by meta-analysis using reports in various ethnic groups. Taken together with these results, PPARγ is a thrifty gene mediating type 2 diabetes both in mice and humans. Indeed, pharmacological inhibitors of PPARγ/RXR ameliorates high-fat diet-induced insulin resistance in animal models of type 2 diabetes.
本文言語 | 英語 |
---|---|
ページ(範囲) | 317-324 |
ページ数 | 8 |
ジャーナル | Folia Pharmacologica Japonica |
巻 | 122 |
号 | 4 |
DOI | |
出版ステータス | 出版済み - 2003 |
ASJC Scopus 主題領域
- 薬理学